Braun J, Schneider M, Lakomek H-J
Rheumazentrum Ruhrgebiet, Claudiusstr. 45, 44649, Herne, Deutschland.
Rheumatologie, Universität Düsseldorf, Düsseldorf, Deutschland.
Z Rheumatol. 2016 Mar;75(2):203-12. doi: 10.1007/s00393-016-0054-x.
The recently passed German hospital structure act (Krankenhausstrukturgesetz) stresses the immense importance of quality for the medical care of the population. How can inpatient and outpatient treatment in the field of rheumatology be improved and how can this be assessed? A very important basis for such measurement approaches are quality indicators, i.e. parameters that indicate to what degree a certain level of quality has already been reached or is planned to be reached in the future. The work performed by the German Rheumatism Research Center (DRFZ) and the Association of Rheumatological Acute Clinics (VRA) in Germany has already used certain quality indicators and this topic has been recently described elsewhere. International quality indicators have also been published in recent years, all for rheumatoid arthritis (RA), the most prevalent inflammatory rheumatic disease and are the central subject of this article. This overview of proposed instruments for quality assessment in rheumatology is intended to initiate a broad discussion on the subject of quality of rheumatological care in Germany.
最近通过的德国医院结构法案(《医院结构法》)强调了质量对于民众医疗保健的极其重要性。在风湿病领域,住院和门诊治疗如何能够得到改善,又如何对此进行评估呢?此类衡量方法的一个非常重要的基础是质量指标,即表明在何种程度上已经达到或计划在未来达到某一质量水平的参数。德国风湿病研究中心(DRFZ)和德国风湿病急性诊所协会(VRA)在德国所开展的工作已经使用了某些质量指标,并且这一主题最近在其他地方也有描述。近年来还公布了国际质量指标,所有这些指标都是针对类风湿关节炎(RA)的,类风湿关节炎是最常见的炎性风湿性疾病,也是本文的核心主题。本风湿病质量评估拟议工具概述旨在引发关于德国风湿病护理质量主题的广泛讨论。